Turnover of Vilniaus Baldai AB during period 2010 January – March was 43 193 thousand LTL (12 510 thousand EUR), same period year 2009 – 34 827 thousand LTL (10..
MoreHBM Pharma s.r.o (100% controled by Sanitas AB) established subsidiary Sanitas Pharma JSC. Marketing, sales and regulatory organization will be separated from HBM Pharma s.r.o. and transferred to newly established..
MoreShareholders of investment company Invalda approved results for 2009, covered losses from reserves, reelected board and audit committee members and also approved employees stock option grants policy during shareholders meeting..
MoreOn 30 April, 2010, the ordinary General Shareholders meeting of Invalda shareholders 1. Get acquainted with the Auditor‘s report and the report of the Audit Committee. 2. Get acquainted with..
MoreOn the 29th of April 2010 the Annual General Shareholders Meeting of Vilniaus baldai AB adopted the following resolutions: Item 1 of the Agenda: Consolidated annual report.The Company‘s consolidated annual report..
MoreSanitas, AB Ordinary General Shareholders Meeting held on April 28, 2010 decided: 1. Company‘s auditor‘s report.1.1. To take into account Company‘s auditor’s report when voting for the approval of Sanitas,..
MoreOn April 27, 2010 the agreement on sale of Sanitas, AB subsidiary HBM Pharma s.r.o. was signed between Sanitas, AB and Latvian company SIA Liplats 2000. The parties agreed that..
MoreInvestment group Invalda announces audited results for 2009, which do not materially differ from preliminary announcement. Invalda group’s loss attributed to equity holders of the parent company after the audit..
MoreThe Management Board of Invalda AB approved the draft resolutions of the Ordinary General Shareholders meeting to be held on April 30, 2010 1. Auditor‘s report.To get acquainted with Company‘s..
More